Oasmia Pharmaceutical AB
Correction of notice regarding notice of Annual General Meeting
Oasmia Pharmaceutical AB 01.09.2014 13:30 Dissemination of a Adhoc News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Uppsala, Sweden, 2014-09-01 13:30 CEST (GLOBE NEWSWIRE) -- In the English translation of the notice, the suggestion for re-election of the board should read Joel Citron, Horst Domdey, Alexander Kotsinas, Bo Cederstrand and Julian Aleksov, and election of Hans Sundin. Mikael Widell, Vice President Communications Mobile: +46 70 311 99 60 E-mail: mikael.widell@oasmia.com News Source: NASDAQ OMX 01.09.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Oasmia Pharmaceutical AB Sweden Phone: Fax: E-mail: Internet: ISIN: SE0000722365 WKN: End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden